About Us

Cali Biosciences is an international biopharmaceutical company dedicated to the research and development of innovative drugs. We have an international team of scientific research and management talents and is developing new drugs based on several licensed technology platforms. We focus on the R&D of perioperative drugs. The product pipeline includes new drugs in the fields of anesthesia, analgesia and anti-inflammatory. In the future, we will also promote the commercialization of products to fully respond to the unmet market demand.

The company focuses on the research and development of innovative drugs, with laboratorie and offices in Shenzhen, China, and offices in San Diego, USA, and a clinical center in Shanghai, China.

The company's main business is the research and development, and commercialization of innovative drugs. The current product pipeline consists of several modified new drugs based on the 505(b)(2) regulatory pathways. During the R&D process and upon completing the clinical trials, we seek approval from China, US and EU regulatory agencies and aiming at bringing innovative drugs in global markets. We are building a perioperative medication (anesthesia, analgesia and anti-inflammatory) pipeline to meet the global unmet needs. At present, we have several clinical and pre-clinical stage drug candidates, the target market of the product pipeline is huge, and the clinical needs are clear. All the products in pipeline are complex injectable products covered under high technology patent.

Our mission is to improve the length and quality of human life.